Psychemedics Q3 EPS $(0.36) Down From $(0.02) YoY, Sales $5.70M Down From $6.52M YoY
Portfolio Pulse from Benzinga Newsdesk
Psychemedics (NASDAQ:PMD) reported Q3 losses of $(0.36) per share, a 1700% decrease YoY. The company also reported a 12.46% decrease in sales to $5.70 million compared to $6.52 million in the same period last year.
November 10, 2023 | 12:05 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Psychemedics reported a significant YoY decrease in Q3 earnings and sales, which could negatively impact its stock price.
Psychemedics reported a significant decrease in Q3 earnings and sales compared to the same period last year. This indicates a poor financial performance, which could lead to a decrease in investor confidence and a potential drop in the company's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100